Status:
COMPLETED
Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis
Lead Sponsor:
University Health Network, Toronto
Conditions:
Renal Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Introduction: Narrowing of the draining vein occurs in \>50% of hemodialysis fistula and left untreated will lead to loss of access. The narrowing is due to excessive growth of tissue in the vessel wa...
Eligibility Criteria
Inclusion
- Hemodialysis access located in the forearm or upper arm
- Patient with clinical or hemodynamic evidence of graft dysfunction
- Hemodialysis access is \> 3 months old
Exclusion
- Intervention of the vascular access circuit within the past 30 days
- Thrombosed/clotted access
- Evidence of systemic infection or a local infection associated with the graft
- Positive pregnancy test within 7 days before enrolment
- Patient is scheduled for a kidney transplant
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01001676
Start Date
February 1 2012
End Date
July 1 2014
Last Update
November 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2N2